Skip to Main Content

Paper Details

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains.
Nature
183
2021
2B04, B, B., B.1, B.1.1.28, B.1.351, CoV, K18, LY-CoV016, LY-CoV555, SARS, SARS-, SARS-CoV, SARS-CoV-2, anti-, cell culture, hACE2, mice, spike
Author NameAffiliation
Rita E ChenWashington University School of Medicine
Rita E ChenWashington University School of Medicine
Laura A VanBlarganWashington University School of Medicine
Xuping XieUniversity of Texas Medical Branch
Pavlo GilchukVanderbilt University Medical Center
Scott A HandleyWashington University School of Medicine
Pei-Yong ShiUniversity of Texas Medical Branch
Pei-Yong ShiUniversity of Texas Medical Branch
Pei-Yong ShiSealy Institute for Vaccine Sciences, University of Texas Medical Branch
Mehul S SutharCenter for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Emory University School of Medicine
Raul AndinoUniversity of California San Francisco
Charles Y ChiuUniversity of California San Francisco
Charles Y ChiuUniversity of California San Francisco
James E CroweVanderbilt University Medical Center
James E CroweVanderbilt University Medical Center
James E CroweVanderbilt University Medical Center
Adrianus C M BoonWashington University School of Medicine
Adrianus C M BoonWashington University School of Medicine
Adrianus C M BoonWashington University School of Medicine
  • 1 - 19

Datasets

Release 1.2